Index removals put CareTrust REIT back in focus

CareTrust REIT (CTRE) has been removed from several Russell growth benchmarks, a reshuffle that can change how index funds and other rules-based investors trade the stock.

This index action arrives shortly after CareTrust REIT affirmed a quarterly common dividend of $0.39 per share, payable in mid July to stockholders of record at the end of June.

CareTrust REIT's recent index removals appear to have coincided with increased trading interest. The stock has a 2.59% 1-day share price return and a 12.45% year-to-date share price return, while its 1-year total shareholder return of 37.44% and 3-year total shareholder return of about 13x indicate that momentum has been building over a longer horizon.

If you are comparing CareTrust REIT with other income-focused ideas, it can be useful to scan beyond real estate and see what else is gaining attention, including 20 top founder-led companies

With CareTrust REIT now removed from several Russell growth indexes, yet trading at a discount to the average analyst price target and carrying a value score of 4, is the stock being overlooked or is the market already accounting for what comes next?

Most Popular Narrative: 10.3% Undervalued

The most followed narrative on CareTrust REIT currently points to a fair value of $45.50 against a last close of $40.83, setting up a debate around whether the stock is pricing in its growth and income ambitions.

The expanded investment pipeline of approximately $600 million, mainly in skilled nursing, seniors housing, and U.K. care homes, gives strong visibility into continued external growth, bolstering FFO and supporting durable, long-term dividend increases.

Want to see what is backing that higher fair value for CareTrust REIT? The core narrative leans on rapid portfolio expansion, changing margins, and a richer future earnings multiple that has been modeled out in detail, but not yet tested in real time.

Result: Fair Value of $45.50 (UNDERVALUED)

However, the CareTrust REIT story could look different if rapid portfolio expansion brings integration missteps, or if regulatory changes pressure skilled nursing and senior housing tenants.

Another view on CareTrust REIT’s valuation

The earlier fair value view for CareTrust REIT leans on long term earnings forecasts and a target P/E of 32.7x. Looking at today’s pricing instead, the stock trades on a 28.8x P/E, above the Global Health Care REITs industry at 20.2x and below its fair ratio of 39.7x. This points to both valuation risk and potential upside if the market ever moves closer to that fair ratio.

One approach frames CareTrust REIT as undervalued relative to its cash flow outlook. In contrast, this P/E comparison suggests the stock is already priced at a premium to the broader industry. That leaves you to decide which reference point feels more realistic for the next phase of the story.

Next Steps

Given the mix of optimism and concern around CareTrust REIT, it makes sense to look at the data firsthand and decide where you stand. A good place to start is the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond CareTrust REIT?

If you want a broader context for CareTrust REIT and do not want to miss other potential opportunities, it helps to scan a few focused stock lists.

Use the Simply Wall St screener to spot more ideas that fit your style so you can compare them directly with CareTrust REIT's risk and return profile.

• Target potential upside by running through 44 high quality undervalued stocks that combine solid fundamentals with pricing that may not fully reflect their current metrics.
• Prioritise resilience by reviewing 69 resilient stocks with low risk scores that score well on stability so you are not relying on just one stock to manage downside.
• Explore additional candidates by checking the screener containing 19 high quality undiscovered gems as part of your broader research process.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.